APPLIED DNA SCIENCES INC's ticker is and the CUSIP is 03815U300. A total of 22 filers reported holding APPLIED DNA SCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $793 | -6.2% | 655 | 0.0% | 0.00% | – |
| Q2 2023 | $845 | -67.0% | 655 | -71.1% | 0.00% | – |
| Q1 2023 | $2,564 | -93.6% | 2,269 | -90.6% | 0.00% | – |
| Q4 2022 | $40,134 | -49.2% | 24,177 | -65.1% | 0.00% | – |
| Q3 2022 | $79,000 | – | 69,363 | +10789.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 637 | -88.4% | 0.00% | – |
| Q1 2022 | $12,000 | -47.8% | 5,479 | -5.1% | 0.00% | – |
| Q4 2021 | $23,000 | -36.1% | 5,775 | -13.0% | 0.00% | – |
| Q3 2021 | $36,000 | -5.3% | 6,637 | +17.8% | 0.00% | – |
| Q2 2021 | $38,000 | -5.0% | 5,636 | +0.3% | 0.00% | – |
| Q1 2021 | $40,000 | +37.9% | 5,618 | +0.3% | 0.00% | – |
| Q4 2020 | $29,000 | -85.3% | 5,601 | -78.1% | 0.00% | – |
| Q3 2020 | $197,000 | -34.3% | 25,526 | -31.4% | 0.00% | – |
| Q2 2020 | $300,000 | +25.0% | 37,206 | -37.6% | 0.00% | – |
| Q1 2020 | $240,000 | +1614.3% | 59,641 | +1731.7% | 0.00% | – |
| Q4 2019 | $14,000 | – | 3,256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 751,780 | $849,511 | 0.12% |
| SABBY MANAGEMENT, LLC | 73,553 | $83,115 | 0.07% |
| Cowen Prime Advisors LLC | 98,301 | $95 | 0.04% |
| Atria Wealth Solutions, Inc. | 81,210 | $91,767 | 0.00% |
| Advisory Services Network, LLC | 1 | $1 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 50,892 | $57,508 | 0.00% |
| UBS Group AG | 12,188 | $13,772 | 0.00% |
| NewEdge Advisors, LLC | 2 | $2 | 0.00% |
| Moisand Fitzgerald Tamayo, LLC | 2,000 | $2,260 | 0.00% |
| OSAIC HOLDINGS, INC. | 2 | $2 | 0.00% |